At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed Nov 2, 2026 at 05:00 ET
OraSure Technologies announced its membership in the World Coalition on Sickle Cell Disease, a public-private partnership focused on improving global sickle cell disease care. The company will contribute diagnostics expertise, particularly in decentralized and point-of-care testing, to support early diagnosis and linkage to care. No financial terms or material revenue impact were disclosed.
- OraSure joined the World Coalition on Sickle Cell Disease, an international public-private partnership.
- The coalition includes patient advocacy groups, governments, healthcare providers, researchers, and private sector entities.
- OraSure will provide a diagnostics manufacturer perspective, focusing on decentralized and point-of-care testing.
- No financial terms, contract value, or revenue guidance were disclosed in the announcement.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access